Integrative Therapy in Alcoholism
Acamprosate and Integrative Behavior Therapy in the Outpatient Treatment of Alcohol Dependents
1 other identifier
interventional
371
1 country
1
Brief Summary
The main aim of this project consists in the investigation of the interaction of behavior therapy and Acamprosate in the outpatient treatment of alcoholic patients in a randomized, prospective and (regarding study medication Acamprosate vs. Placebo) double blind design. A total of 371 patients has been randomly assigned immediately after detoxification to one of three different outpatient treat-ment conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started May 2003
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 7, 2005
CompletedFirst Posted
Study publicly available on registry
September 12, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedJanuary 30, 2008
October 1, 2007
September 7, 2005
January 29, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Abstinence
3,6,12 months
Secondary Outcomes (2)
Social functioning
12 months
Cognitive functioning
12 months
Study Arms (3)
2
EXPERIMENTALPlacebo +Integrative behavior therapy
3
EXPERIMENTALAcamprosate + treatment as usual
1
EXPERIMENTALAcamprosate + Integrative behavior therapy
Interventions
Eligibility Criteria
You may qualify if:
- DSMIV criteria of alcoholism
- Age between 25 and 60
- Informed consent
You may not qualify if:
- Residence outside of the catchment area
- Legal reasons
- Insufficient knowledge of the German language
- Substance abuse or addiction other than alcohol or nicotine
- Pregnancy
- Serious physical illness
- Organic brain disease
- Contraindication to Acamprosate treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Heinrich-Heine University, Duesseldorflead
- German Federal Ministry of Education and Researchcollaborator
- German Addiction Research Networkcollaborator
- Merck Sharp & Dohme LLCcollaborator
- University of Bonncollaborator
- Universität Duisburg-Essencollaborator
- University of Homburgcollaborator
- Psychosomatic Clinic of Bergisch Gladbachcollaborator
Study Sites (1)
Department of Psychiatry and Psychotherapy at the Heinrich-Heine-University Düsseldorf, Rhineland State Clinics Düsseldorf, Bergische Landstraße 2, 40629 Düsseldorf, Germany
Düsseldorf, North Rhine-Westfalia, 40629, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Wolfgang Gaebel, Professor
Department of Psychiatry and Psychotherapy, University of Düsseldorf
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 7, 2005
First Posted
September 12, 2005
Study Start
May 1, 2003
Study Completion
December 1, 2006
Last Updated
January 30, 2008
Record last verified: 2007-10